Comparison Chart Prothena Corporation plc

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 10/06/2024 BST			5-day change	1st Jan Change
21.04 ^USD	-0.43%		-5.10%	-42.10%

05-28	Prothena to Receive $80 Million From Bristol-Myers Squibb For PRX019 Global License	MT
05-28	Prothena Announces Bristol Myers Squibb Opt-In for Exclusive Global License for PRX019, the Second Program from Global Neuroscience Research and Development Collaboration	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	PROTHENA CORPORATION PLC	Bio Therapeutic Drugs	-0.43%	-5.10%	-42.10%	-69.73%	+127.71%	1.13B